✓ No loaded language, vague sourcing, or framing detected.
The FDA has granted approval for Moderna's mRNA flu vaccine, which utilizes a new preparation method. This method is designed to allow countries to choose the most suitable flu strain for their populations each season.
Our neutral summary
The FDA has granted approval for Moderna's mRNA flu vaccine, which utilizes a new preparation method. This method is designed to allow countries to choose the most suitable flu strain for their populations each season.
The reporting belongs to New York Times — Business; we don't reproduce it.
No note attached
on this article.
F.D.A. Approves Moderna’s mRNA Flu Vaccine
FDA Approves Moderna's mRNA Flu Vaccine